May 09, 2025 11:00
BOLD - Boundless Bio, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 1.28 0.05 (4.3%) | --- | --- | --- | 0.0 (0.0%) | 0.01 (1.14%) | --- | 0.0 (0.0%) |
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
AfterHours
Earnings & Ratios
- Basic EPS:
- -0.7
- Diluted EPS:
- -0.7
- Basic P/E:
- -1.9071
- Diluted P/E:
- -1.9071
- RSI(14) 1m:
- 46.15
- VWAP:
- 1.34
- RVol:
- 1.1387
Events
| Period | Kind | Movement | Occurred At |
|---|---|---|---|
| 1m | Price increase 1m | 1.34 +0.01 (+1.14%) | Oct 15 15:58 |
| 1m | Price increase 1m | 1.34 +0.01 (+1.14%) | Oct 15 15:52 |
| 1m | Price increase 1m | 1.34 +0.02 (+1.52%) | Oct 15 15:45 |
| 1m | Price decrease 1m | 1.33 -0.02 (-1.12%) | Oct 15 15:25 |
| 1m | Price increase 1m | 1.3 +0.02 (+1.56%) | Oct 15 11:49 |
Related News
Apr 03, 2025 11:00
Sep 11, 2024 11:00
Apr 21, 2024 10:46